scorecardresearch
Wednesday, August 6, 2025
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

Where is Skill India money going? It’s a Rs 48,000 crore mystery

All industries are still facing an acute shortage of skilled manpower despite thousands of crores spent on skilling schemes.

BJP MPs go full throttle against Trump even as govt hails enduring India-US ties amid tariff tension

New Delhi: While the Indian government has made a measured response to the 25 percent trade tariff imposed by Donald Trump, many in the BJP...

Trump feared India could arm BrahMos with nuclear warhead to target Pakistan in Op Sindoor—WSJ report

New Delhi: During Operation Sindoor, the United States which had received intelligence suggesting that India had launched BrahMos cruise missiles to strike targets inside...

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.